NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
| NCT ID | NCT04075305 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2019-02-01 |
| Primary Completion | 2030-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2019-02-01 with a primary completion date of 2030-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Eligibility Criteria
Inclusion Criteria: * Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac; * Patient provides written, informed consent; * Patient is 18 years old or older. Exclusion Criteria: * MRI exclusion criteria, including * MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
Contact & Investigator
Helena M Verkooijen, Prof, Dr
PRINCIPAL INVESTIGATOR
Universitair Medical Centre Utrecht
Frequently Asked Questions
Who can join the NCT04075305 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04075305 currently recruiting?
Yes, NCT04075305 is actively recruiting participants. Contact the research team at T.Leer@umcutrecht.nl for enrollment information.
Where is the NCT04075305 trial being conducted?
This trial is being conducted at Pittsburgh, United States, Houston, United States, Milwaukee, United States, Melbourne, Australia and 11 additional locations.
Who is sponsoring the NCT04075305 clinical trial?
NCT04075305 is sponsored by UMC Utrecht. The principal investigator is Helena M Verkooijen, Prof, Dr at Universitair Medical Centre Utrecht. The trial plans to enroll 8,000 participants.